<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>neurodegenerative diagnostics &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/neurodegenerative-diagnostics/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 18 Apr 2025 14:37:25 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>neurodegenerative diagnostics &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Ahead-of-Print Highlights from The Journal of Nuclear Medicine – April 18, 2025</title>
		<link>https://bioengineer.org/ahead-of-print-highlights-from-the-journal-of-nuclear-medicine-april-18-2025/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 18 Apr 2025 14:37:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CAR T therapy monitoring]]></category>
		<category><![CDATA[molecular imaging]]></category>
		<category><![CDATA[neurodegenerative diagnostics]]></category>
		<category><![CDATA[PET radiotracers]]></category>
		<category><![CDATA[precision oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ahead-of-print-highlights-from-the-journal-of-nuclear-medicine-april-18-2025/</guid>

					<description><![CDATA[Reston, VA (April 18, 2025)—In a series of breakthrough developments, The Journal of Nuclear Medicine (JNM) has unveiled pioneering research that promises to revolutionize diagnostic imaging and precision medicine in oncology and neurology. These newly published studies leverage cutting-edge molecular imaging technologies to enhance the detection, differentiation, and prognosis of complex diseases, representing significant strides [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">241506</post-id>	</item>
	</channel>
</rss>
